Literature DB >> 11259719

Paternal and maternal components of the predisposition to preeclampsia.

M S Esplin1, M B Fausett, A Fraser, R Kerber, G Mineau, J Carrillo, M W Varner.   

Abstract

BACKGROUND: There is an inherited maternal predisposition to preeclampsia. Whether there is a paternal component, however, is not known.
METHODS: We used records of the Utah Population Database to identify 298 men and 237 women born in Utah between 1947 and 1957 whose mothers had had preeclampsia during their pregnancy. For each man and woman in the study group, we identified two matched, unrelated control subjects who were not the products of pregnancies complicated by preeclampsia. We then identified 947 children of the 298 male study subjects and 830 children of the 237 female study subjects who had been born between 1970 and 1992. These children were matched to offspring of the control subjects (1950 offspring of the male control group and 1658 offspring of the female control group). Factors associated with preeclampsia were identified, and odds ratios were calculated with the use of stepwise logistic-regression analysis.
RESULTS: In the group whose mothers had had preeclampsia (the male study group), 2.7 percent of the offspring (26 of 947) were born of pregnancies complicated by preeclampsia, as compared with 1.3 percent of the offspring (26 of 1973) in the male control group. In the female study group, 4.7 percent of the pregnancies (39 of 830) were complicated by preeclampsia, as compared with 1.9 percent (32 of 1658) in the female control group. After adjustment for the offspring's year of birth, maternal parity, and the offspring's gestational age at delivery, the odds ratio for an adult whose mother had had preeclampsia having a child who was the product of a pregnancy complicated by preeclampsia was 2.1 (95 percent confidence interval, 1.0 to 4.3; P=0.04) in the male study group and 3.3 (95 percent confidence interval, 1.5 to 7.5; P=0.004) in the female study group.
CONCLUSIONS: Both men and women who were the product of a pregnancy complicated by preeclampsia were significantly more likely than control men and women to have a child who was the product of a pregnancy complicated by preeclampsia.

Entities:  

Mesh:

Year:  2001        PMID: 11259719     DOI: 10.1056/NEJM200103223441201

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  88 in total

Review 1.  Preeclampsia, an implantation disorder.

Authors:  Leslie L Waite; Amy K Atwood; Robert N Taylor
Journal:  Rev Endocr Metab Disord       Date:  2002-05       Impact factor: 6.514

2.  Susceptibility loci for preeclampsia on chromosomes 2p25 and 9p13 in Finnish families.

Authors:  Hannele Laivuori; Päivi Lahermo; Vesa Ollikainen; Elisabeth Widen; Leena Häivä-Mällinen; Helena Sundström; Tarja Laitinen; Risto Kaaja; Olavi Ylikorkala; Juha Kere
Journal:  Am J Hum Genet       Date:  2002-12-09       Impact factor: 11.025

3.  Maternal activating KIRs protect against human reproductive failure mediated by fetal HLA-C2.

Authors:  Susan E Hiby; Richard Apps; Andrew M Sharkey; Lydia E Farrell; Lucy Gardner; Arend Mulder; Frans H Claas; James J Walker; Christopher W Redman; Christopher C Redman; Linda Morgan; Clare Tower; Lesley Regan; Gudrun E Moore; Mary Carrington; Ashley Moffett
Journal:  J Clin Invest       Date:  2010-10-25       Impact factor: 14.808

4.  Molecular and vascular targets in the pathogenesis and management of the hypertension associated with preeclampsia.

Authors:  Ossama M Reslan; Raouf A Khalil
Journal:  Cardiovasc Hematol Agents Med Chem       Date:  2010-10-01

5.  Associations of ACE I/D, AGT M235T gene polymorphisms with pregnancy induced hypertension in Chinese population: a meta-analysis.

Authors:  Ming Zhu; Jie Zhang; Shaofa Nie; Weirong Yan
Journal:  J Assist Reprod Genet       Date:  2012-05-30       Impact factor: 3.412

Review 6.  Genetic, immune and vasoactive factors in the vascular dysfunction associated with hypertension in pregnancy.

Authors:  Sajjadh M J Ali; Raouf A Khalil
Journal:  Expert Opin Ther Targets       Date:  2015-08-17       Impact factor: 6.902

7.  Male reproductive proteins and reproductive outcomes.

Authors:  Roberta B Ness; David A Grainger
Journal:  Am J Obstet Gynecol       Date:  2008-01-14       Impact factor: 8.661

Review 8.  Current Updates on Pre-eclampsia: Maternal and Foetal Cardiovascular Diseases Predilection, Science or Myth? : Future cardiovascular disease risks in mother and child following pre-eclampsia.

Authors:  Samson A Odukoya; Jagidesa Moodley; Thajasvarie Naicker
Journal:  Curr Hypertens Rep       Date:  2021-03-10       Impact factor: 5.369

Review 9.  Bioactive factors in uteroplacental and systemic circulation link placental ischemia to generalized vascular dysfunction in hypertensive pregnancy and preeclampsia.

Authors:  Dania A Shah; Raouf A Khalil
Journal:  Biochem Pharmacol       Date:  2015-04-24       Impact factor: 5.858

10.  Risk of Ischemic Placental Disease in Relation to Family History of Preeclampsia.

Authors:  Cande V Ananth; Kathleen Jablonski; Leslie Myatt; James M Roberts; Alan T N Tita; Kenneth J Leveno; Uma M Reddy; Michael W Varner; John M Thorp; Brian M Mercer; Alan M Peaceman; Susan M Ramin; Marshall W Carpenter; Philip Samuels; Anthony Sciscione; Jorge E Tolosa; George Saade; Yoram Sorokin
Journal:  Am J Perinatol       Date:  2018-10-03       Impact factor: 1.862

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.